A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2023-048 B 股证券代码：900906 B 股证券简称：中毅达 B 公司本次发行股份购买资产并募集配套资金暨关联交易事项尚需上交所审 核通过并报中国证监会注册，能否审核通过、完成注册及最终审核通过、完成注 册的时间尚存在不确定性。公司将根据该事项的进展情况及时履行信息披露义 务。公司指定信息披露媒体为《中国证券报》《上海证券报》和上交所网站 （www.sse.com.cn）。有关公司信息均以在上述指定媒体披露的公告为准，敬请 广大投资者注意投资风险。 特此公告。 贵州中毅达股份有限公司董事会 2023 年 8 月 25 日 贵州中毅达股份有限公司（以下简称"公司"）拟以发行股份方式购买瓮福 （集团）有限责任公司 100%股权并募集配套资金（以下简称"本次重组"）。 2023 年 3 月 2 日，公司收到上海证券交易所（以下简称"上交所"）出具 的《关于受理贵州中毅达股份有限公司发行股份购买资产并募集配套资金申请的 通知》（上证上审〔2023〕2 号），上交所依据相关规定对公司报送的发行股份 购买资产并募集配套资金的申请文件进行了核对，认为 ...

A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2023-046 B 股证券代码：900906 B 股证券简称：中毅达 B 贵州中毅达股份有限公司 第八届监事会第二十一次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 贵州中毅达股份有限公司（以下简称"公司"）第八届监事会第二十一次会 议（以下简称"本次会议"）于 2023 年 8 月 25 日以通讯表决的方式召开。会议 应参加表决监事 3 名，亲自出席监事 3 名。 监事会主席夜文彦先生召集和主持了本次会议。本次会议的召开符合有关法 律、法规及《公司章程》的规定。 二、监事会会议审议情况 （一） 审议通过《关于<2023 年半年度报告>及摘要的议案》 经审议，监事会认为：公司《2023 年半年度报告》及摘要的编制、审议符 合相关法律法规及《公司章程》的规定。公司编制的《2023 年半年度报告》及 摘要真实、准确、完整地反映了公司的财务状况和经营成果，不存在任何虚假记 载、误导性陈述或重大遗漏，未发现参与《2023 年半年度报告》编制和审议的 人员 ...

上海市方达律师事务所 关于贵州中毅达股份有限公司 发行股份购买资产并募集配套资金暨关联交易的 补充法律意见书（七） 2023 年 8 月 FANGDA PARTNERS 上海 Shanghai·北京 Beijing·深圳 Shenzhen·广州 Guangzhou 香港 Hong Kong· http://www.fangdalaw.com | 中国上海市石门一路 288 号 | 电子邮件 E-mail: email@fangdalaw.com | | | | --- | --- | --- | --- | | 兴业太古汇香港兴业中心二座 24 楼 | 电 话 | Tel.: | 86-21-2208-1166 | | 邮政编码：200041 | 传 真 | Fax: | 86-21-5298-5599 | 24/F, HKRI Centre Two, HKRI Taikoo Hui 288 Shi Men Yi Road Shanghai 200041, China 上海市方达律师事务所 关于贵州中毅达股份有限公司 发行股份购买资产并募集配套资金暨关联交易的 补充法律意见书（七） 致：贵州中毅达股份有限公司 ...

A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2023-026 B 股证券代码：900906 B 股证券简称：中毅达 B 贵州中毅达股份有限公司 关于参加 2022 年度贵州辖区上市公司业绩说明会暨 投资者集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 5 月 17 日（星期三）15:30-17:00 会议召开方式：网络远程方式 投资者可于本公告发出之日起至 2023 年 5 月 15 日，通过微信关注"贵 州资本市场"公众号，发送关键词"提问"即可进入专区提问。公司将在本 次说明会上对投资者普遍关注的问题进行回答。 贵州中毅达股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日于《中 国证券报》《上海证券报》及上海证券交易所网站（www.sse.com.cn）发布公司 2022 年年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、 财务状况，公司将参加在贵州证监局指导下、贵州证券业协会联合深圳市全景网 络 ...

A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2023-026 B 股证券代码：900906 B 股证券简称：中毅达 B 贵州中毅达股份有限公司 关于参加 2022 年度贵州辖区上市公司业绩说明会暨 投资者集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于本公告发出之日起至 2023 年 5 月 15 日，通过微信关注"贵 州资本市场"公众号，发送关键词"提问"即可进入专区提问。公司将在本 次说明会上对投资者普遍关注的问题进行回答。 贵州中毅达股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日于《中 国证券报》《上海证券报》及上海证券交易所网站（www.sse.com.cn）发布公司 2022 年年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、 财务状况，公司将参加在贵州证监局指导下、贵州证券业协会联合深圳市全景网 络有限公司举办的"2022 年度贵州辖区上市公司业绩说明会暨投资者集体接待 日"活动。 一、说明会类型 本次 ...

Financial Performance - The company reported a cumulative undistributed profit balance of -1,995.42 million RMB at the end of 2022, resulting in no profit distribution or capital reserve increase plan for the year[5]. - The company's operating revenue for 2022 was approximately ¥1.366 billion, a decrease of 2.01% compared to ¥1.394 billion in 2021[24]. - Net profit attributable to shareholders was ¥11.116 million in 2022, down 73.46% from ¥41.888 million in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥9.390 million, reflecting an 83.66% decline from ¥57.457 million in 2021[24]. - The net cash flow from operating activities decreased by 23.28% to ¥58.777 million from ¥76.609 million in 2021[24]. - The company's total assets at the end of 2022 were approximately ¥1.287 billion, a decrease of 5.52% from ¥1.362 billion at the end of 2021[24]. - Basic earnings per share for 2022 were ¥0.0104, down 73.40% from ¥0.0391 in 2021[25]. - The weighted average return on equity decreased to 8.09% in 2022, down 29.69 percentage points from 37.78% in 2021[25]. - The gross margin for polyol products significantly declined due to a drop in product prices, which fell more than the decrease in raw material prices[26]. - The gross profit margin for pentaerythritol products decreased significantly in 2022 due to rising raw material prices and weakened downstream demand[57]. - The company achieved a revenue of CNY 136,600.38 million and a net profit of CNY 1,111.59 million, with a slight decline in main business revenue by 1.16% compared to the previous year[39]. Corporate Governance - The company held one annual general meeting and three extraordinary general meetings during the reporting period, passing 15 resolutions to ensure shareholder rights are protected[140]. - The board of directors consists of seven members, including three independent directors, and has convened nine meetings, passing 35 resolutions, ensuring compliance with legal requirements[140]. - The supervisory board held eight meetings, passing 23 resolutions, maintaining effective oversight of the company's operations and financial status[141]. - The company disclosed 68 announcements and 79 other disclosure documents during the reporting period, ensuring transparency and timely information for investors[141]. - There were no instances of related party transactions harming the interests of the company or its shareholders during the reporting period[142]. - The company has implemented measures to maintain independence from its controlling shareholder, ensuring no interference in decision-making processes[142]. - The company is focused on compliance and transparency in its shareholder meetings, adhering to legal and regulatory requirements[145]. - The company’s independent directors have diverse backgrounds, including finance and law, enhancing governance[148]. - The company is committed to maintaining rigorous standards in its corporate governance practices[145]. Risk Management - The company has detailed potential risks in its report, particularly in the section discussing future development and risks[9]. - The company emphasizes the importance of investor awareness regarding the risks associated with forward-looking statements in its report[6]. - The company has faced risks related to safety and environmental compliance due to the nature of its chemical production processes[131]. - The company has not experienced goodwill impairment as of the end of 2022, but future industry conditions could pose risks[134]. - The company is undergoing a major asset restructuring to acquire 100% of Wengfu Group, which will significantly reduce its debt-to-asset ratio and eliminate liquidity risks on a consolidated basis[136]. Research and Development - The company has applied for 5 new invention patents and received 3 authorized invention patents during the reporting period, enhancing its innovation capabilities[40]. - The company has developed a total of 46 patents, including 9 invention patents, with a core patent for the production method of pentaerythritol[59]. - The company has established a research and development model in collaboration with renowned universities, enhancing its R&D capabilities and technological level[59]. - The company has established a complete new product R&D process covering all stages from project initiation to industrial production[104]. - The company has a total of 123 R&D personnel, including 7 core R&D staff, focusing on enhancing product competitiveness and extending the industrial chain[106]. Environmental Compliance - The company has implemented a three-year action plan for hazardous waste safety management, resulting in no environmental pollution incidents during the reporting period[41]. - The company has established a comprehensive environmental management system, achieving compliance with the pollution discharge permit management regulations[41]. - The company has maintained compliance with environmental discharge standards, with no exceedances reported for key pollutants during the reporting period[182]. - The company has successfully operated multiple pollution control facilities, including a wastewater treatment plant and a waste incineration facility, since their respective commissioning dates[184]. - The company has focused on energy-saving and emission-reduction technologies, optimizing production processes to lower energy consumption[190]. Strategic Initiatives - The company plans to acquire 100% equity of Wengfu Group for a valuation of CNY 1,132,453.93 million, issuing shares at CNY 5.10 per share[33]. - The acquisition will increase the company's main business to include phosphate mining and production, significantly enhancing asset scale and profitability[34]. - The company has applied for administrative approval for the asset acquisition, which is currently under review by the Shanghai Stock Exchange[37]. - The company has filed for a fundraising of up to CNY 166,000 million to support the acquisition and related projects[33]. - The company aims to enhance its competitive advantage in core products like pentaerythritol and trimethylolpropane, while expanding production capacity and optimizing product structure[125]. Operational Efficiency - The company has maintained stable production with an increase in the output of polyol series products, while optimizing product structure based on market demand[39]. - The company plans to optimize production processes and strengthen equipment management to enhance production efficiency[74]. - The company has implemented advanced non-patented technologies in the production of food-grade alcohol, achieving high fermentation conversion rates[107]. - The company has a strategic advantage in procurement, particularly for corn, which is sourced through various channels to optimize costs[53]. - The company is located in a region with favorable logistics and low energy costs, enhancing its competitive edge in production[60]. Financial Management - The company has a debt-to-asset ratio of 88.89% as of December 31, 2022, indicating a high level of financial leverage[135]. - The financing activities resulted in a net cash outflow of RMB 55,055,850.94, a significant increase compared to the previous year[65]. - The company's total cost of raw materials for the multi-functional alcohol segment was CNY 442,251,281.78, accounting for 36.96% of total costs, an increase of 3.86% compared to the previous year[76]. - The company's management expenses decreased by 27.88% to CNY 63,274,000, mainly due to a reduction in employee salary provisions and lower restructuring service fees[82]. - The company has a cash dividend policy in place, which is subject to adjustments based on performance[171]. Employee Management - The company reported a total of 800 employees, with 643 in production, 21 in sales, 61 in technical roles, 12 in finance, 51 in administration, and 12 in supply[167]. - The company has established a performance evaluation system linking individual income directly to operational performance for all employees[168]. - The company has implemented effective training programs to enhance employees' capabilities and promote overall development[169]. - The total remuneration for all directors, supervisors, and senior management personnel for the reporting period amounted to 5.3715 million yuan[155]. Shareholder Relations - The company is committed to providing accurate and complete information regarding the major asset restructuring process, ensuring compliance with relevant laws and regulations[197]. - The company will ensure that any information disclosed during the major asset restructuring is truthful and complete, accepting legal responsibility for any misleading statements[197]. - The company has assured that all disclosures related to the major asset restructuring will be made in accordance with the requirements of the China Securities Regulatory Commission and the stock exchange[197].

Financial Performance - The company's operating revenue for Q1 2023 was CNY 325,861,894.61, representing a decrease of 5.03% compared to the same period last year [5]. - The net profit attributable to shareholders was a loss of CNY 11,743,230.18, a decline of 165.27% year-on-year [5]. - The basic and diluted earnings per share were both CNY -0.0110, reflecting a decrease of 165.48% compared to the previous year [6]. - Total revenue for Q1 2023 was ¥325,861,894.61, a decrease of 5.5% compared to ¥343,129,262.68 in Q1 2022 [21]. - Net profit for Q1 2023 was a loss of ¥11,743,230.18, compared to a profit of ¥17,990,460.87 in Q1 2022, representing a significant decline [22]. - Basic and diluted earnings per share for Q1 2023 were both -¥0.0110, down from ¥0.0168 in Q1 2022 [23]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY 3,044,980.72, down 97.52% from the same period last year [5]. - Cash flow from operating activities generated a net inflow of ¥3,044,980.72, a decrease of 97.5% from ¥122,822,521.70 in Q1 2022 [26]. - Cash received from sales of goods and services was ¥302,005,576.93, down 11.7% from ¥342,014,700.60 in the previous year [25]. - Cash outflow for operating activities totaled ¥303,854,206.08, an increase of 38.3% compared to ¥219,623,636.78 in Q1 2022 [26]. - The total cash and cash equivalents at the end of the period decreased to $44.12 million from $182.64 million year-over-year [27]. - The cash and cash equivalents net increase for the period was -$21.39 million, compared to an increase of $76.61 million in the same period last year [27]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,239,864,169.72, down 3.65% from the end of the previous year [6]. - Current assets totaled CNY 436,563,636.86, down from CNY 467,524,791.35, indicating a decrease of about 6.62% [19]. - Cash and cash equivalents were CNY 52,587,347.56, compared to CNY 74,090,564.06 at the end of 2022, representing a decline of approximately 29.05% [18]. - Accounts receivable increased to CNY 28,786,819.29 from CNY 19,968,098.66, marking a rise of about 44.1% [18]. - Total liabilities decreased to CNY 1,108,434,052.43 from CNY 1,143,852,286.70, a reduction of approximately 3.09% [20]. - The company's equity attributable to shareholders was CNY 131,430,117.29, down from CNY 142,926,240.98, reflecting a decrease of about 8.06% [20]. Operational Challenges - The company adjusted its sales strategy for polyol products due to weakened demand in downstream industries [10]. - The decline in net profit was attributed to the drop in prices of main products, including trimethylolpropane and pentaerythritol, which exceeded the decrease in raw material costs [10]. - The company reported a significant increase in cash payments for bulk raw materials compared to the previous period [11]. - The company plans to focus on cost control and efficiency improvements in response to the current financial challenges [21]. Subsidiary Management - The company has completed the disposal of two subsidiaries, with no actual gains realized from these disposals as of Q1 2023 [16]. - The company is actively monitoring the asset disposal progress of its subsidiary, 盛云投资, to protect the interests of the company and minority shareholders [16]. - The company continues to pursue bankruptcy proceedings for its subsidiary, 厦门中毅达, and is handling cases related to other subsidiaries [16].

Financial Performance - The company's operating revenue for Q3 2022 was ¥353,688,261.65, a decrease of 1.77% compared to the same period last year[7]. - The net profit attributable to shareholders was -¥2,924,102.03, representing a decline of 110.69% year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥4,366,744.56, a decrease of 114.18% compared to the previous year[7]. - The basic and diluted earnings per share were both -¥0.0027, down 110.59% from the same period last year[9]. - Net profit for Q3 2022 was CNY 39,507,398.55, slightly down from CNY 39,655,878.70 in Q3 2021, reflecting a decrease of approximately 0.4%[38]. - Earnings per share for Q3 2022 were CNY 0.0369, compared to CNY 0.0370 in Q3 2021, showing a marginal decline[40]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,187,242,112.74, a decrease of 12.82% compared to the end of the previous year[10]. - The company's current assets totaled approximately CNY 359.82 million, down 25.5% from CNY 482.57 million at the end of 2021[25]. - The total liabilities as of the end of the reporting period were CNY 1,015,087,316.67, down from CNY 1,230,095,836.58 at the same time last year, a reduction of approximately 17.5%[35]. - The total equity attributable to shareholders of the parent company was CNY 172,154,796.07, an increase from CNY 131,802,601.96 in the previous year, representing a growth of about 30.6%[35]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥207,804,442.49, an increase of 107.71%[10]. - Cash inflow from operating activities for the first three quarters of 2022 totaled CNY 1,032,444,854.39, compared to CNY 982,380,944.61 in the same period of 2021, an increase of about 5.1%[40]. - The net cash flow from operating activities was $207,804,442.49, an increase from $100,043,908.40 in the previous period, indicating a strong operational performance[44]. - The total cash outflow from investing activities was $57,280,413.06, compared to $41,366,435.14 previously, reflecting increased investment efforts[44]. - The net cash flow from financing activities showed a significant outflow of $164,557,162.53, worsening from an outflow of $81,288,993.90 in the prior period, suggesting higher debt repayments[44]. Shareholder Information - The company reported a total of 44,339 common shareholders at the end of the reporting period[14]. - The largest shareholder, Xinda Securities - Industrial Bank - Xinda Xingrong No. 4 Collective Asset Management Plan, held 260,000,000 shares, accounting for 24.27% of total shares[14]. Asset Management and Restructuring - The company has completed the disposal of all assets related to Guizhou Zhongyida Construction Engineering Co., Ltd. and Shanghe Construction[22]. - The company is actively promoting the extension of audit and evaluation work related to the major asset restructuring involving the acquisition of 100% equity of Wengfu Group[20]. - The company has submitted a request to the China Securities Regulatory Commission to suspend the review of the restructuring application due to the expiration of evaluation data[20]. - The company is monitoring the asset disposal progress of Shengyun Investment and ensuring compliance with relevant commitments[22]. - The company will continue to disclose the progress of asset disposal in future periodic reports[24]. Cost and Expenses - Total operating costs for the first three quarters of 2022 were CNY 999,122,253.26, up from CNY 973,755,292.35 in 2021, indicating a rise of about 2.6%[35]. - Research and development expenses for Q3 2022 were CNY 12,298,173.44, up from CNY 10,111,372.21 in Q3 2021, marking an increase of approximately 21.6%[35]. - Financial expenses for Q3 2022 were CNY 27,938,250.43, down from CNY 34,568,208.91 in Q3 2021, indicating a decrease of about 19.1%[35]. Cash Management - The ending balance of cash and cash equivalents was $95,213,861.65, down from $75,589,497.97, indicating a decrease in liquidity[46]. - The company paid $281,232,399.28 in debt repayments, which is an increase from $223,074,687.50, highlighting a focus on reducing leverage[44]. - The cash paid to employees was $88,982,969.90, compared to $72,039,665.63, reflecting an increase in workforce compensation[44]. - The cash paid for taxes was $28,351,932.37, a decrease from $31,079,156.82, indicating potential tax efficiency improvements[44]. - The cash inflow from financing activities totaled $123,241,331.70, down from $151,230,000.00, suggesting a reduction in new borrowings[44]. - The cash outflow for investment activities included $50,693,760.00 for asset acquisitions, up from $34,361,185.91, indicating a strategic push for growth[44]. - The impact of exchange rate changes on cash and cash equivalents was $3,183,424.64, contrasting with a negative impact of $136,267.17 previously, showing improved currency stability[44].

Financial Performance - Basic earnings per share for the first half of 2021 increased by 32.18% to CNY 0.0115 compared to CNY 0.0087 in the same period last year[19] - Diluted earnings per share also rose by 32.18% to CNY 0.0115 from CNY 0.0087 year-on-year[19] - The net profit attributable to shareholders after deducting non-recurring gains and losses saw a significant increase of 2,533.33%, reaching CNY 0.0158 compared to CNY 0.0006 in the previous year[19] - The company's operating revenue for the first half of the year reached ¥677,440,967.75, representing a 38.50% increase compared to ¥489,141,913.80 in the same period last year[20] - Net profit attributable to shareholders was ¥12,308,398.53, up 31.47% from ¥9,362,050.39 year-on-year[20] - The net profit after deducting non-recurring gains and losses surged to ¥16,956,351.70, a significant increase of 2,538.79% compared to ¥642,580.73 in the previous year[20] - The total comprehensive income for the first half of 2021 was CNY 12,308,398.53, compared to CNY 9,362,050.39 in the same period of 2020, representing a year-over-year increase of approximately 31.3%[137] Asset and Liability Management - The company's net assets attributable to shareholders increased by 13.94% to ¥102,475,410.89 from ¥89,934,675.51 at the end of the previous year[20] - Total assets decreased by 6.24% to ¥1,307,593,018.95 from ¥1,394,550,974.95 at the end of the previous year[20] - The company's total liabilities decreased, reflecting improved financial stability and management of debt obligations[143] - The company's debt ratio reached 92.16%, indicating a high level of financial leverage[57] - The total amount of guarantees provided by the company during the reporting period was CNY 200 million, which represents 195.17% of the company's net assets[109] Operational Efficiency - The production and sales volume of the main product, polyol series, showed a notable year-on-year increase, contributing to the improved profit level[19] - The operating cost increased to ¥559,398,229.94, up 37.98% from ¥405,423,102.69, primarily due to increased sales volume and rising raw material prices[43] - The company has implemented management improvements and governance structure enhancements, holding 4 shareholder meetings and 9 board meetings during the reporting period[36] - The company continues to focus on technology upgrades and energy-saving improvements to enhance production efficiency and reduce operational defects[37] Market and Product Development - The company operates in the chemical raw materials and products manufacturing industry, focusing on polyol products and edible alcohol[25] - The main business revenue from core products, including pentanediol and trimethylolpropane, increased by 33.23% year-on-year, reaching 639 million yuan[37] - The company plans to adjust its production structure based on market demand and customer orders to maximize economic benefits[29] - The domestic sales of pentanediol remained stable compared to the previous year, while export prices and quantities saw significant increases due to reduced production from foreign competitors[37] Environmental and Safety Management - The company has taken measures to enhance safety and environmental management, with no significant safety or environmental incidents reported during the period[54] - The company is listed as a key pollutant discharge unit by the Chifeng Ecological Environment Bureau, categorized under water, air, and soil environmental key pollutant discharge units[71] - The company operates a wastewater treatment station that has been in operation since June 2015, and it is reported to be functioning well[74] - The company has implemented an emergency response plan for environmental incidents, conducting two drills in the first half of 2021 to ensure preparedness[78] Governance and Compliance - The company did not propose any profit distribution plan or capital reserve transfer to increase share capital during this reporting period[4] - The half-year report has not been audited, but the management guarantees its authenticity and completeness[6] - The company has received environmental impact approvals for multiple projects, with the latest being valid until June 2025[76] - The company guarantees not to use related transactions to transfer funds or profits from the listed company[86] Legal and Financial Challenges - The company has faced significant litigation, with 360 new cases reported since the last annual report, indicating ongoing legal challenges[90] - The company remains at risk of not being able to repay the loan from Wengfu Group on time, highlighting ongoing liquidity risks[58] - The company is actively managing risks associated with international trade tensions and the ongoing COVID-19 pandemic, which may affect product demand[55] - The company is exploring various strategies, including debt restructuring and quality asset injection, to mitigate the impact of legal disputes on its operations[88] Research and Development - The company reported a significant increase in research and development expenses, totaling ¥5,613,777.60 in the first half of 2021, compared to ¥14,050,293.68 in the same period of 2020, reflecting a decrease of 60%[135] - The company holds 47 patents, including 6 invention patents, with a focus on developing new products and technologies in collaboration with top universities[31] Financial Reporting and Accounting - The financial statements are prepared based on the going concern principle, with no identified issues affecting the company's ability to continue operations for the next 12 months[168] - The financial statements comply with the relevant accounting standards, reflecting the company's financial position, operating results, and cash flows accurately[170] - The company uses the Chinese Yuan (RMB) as its functional currency for accounting purposes[173] - The company assesses control over subsidiaries based on the ability to influence returns and has included all subsidiaries in the consolidated financial statements[175]

Financial Performance - Operating revenue for the period from January to September was CNY 770,326,829.64[18] - Net profit attributable to shareholders of the listed company was CNY 8,067,806.18, a significant improvement from a loss of CNY 20,774,062.64 in the same period last year[18] - Basic earnings per share for the period was CNY 0.0075, compared to a loss of CNY 0.0194 per share in the same period last year[20] - The weighted average return on net assets was 16.60%[20] - Total operating revenue for Q3 2020 was ¥281,184,915.84, with year-to-date revenue of ¥770,326,829.64[52] - The company reported a net loss of ¥1,771,215,072.48, compared to a loss of ¥1,779,282,878.66 in the previous period[42] - The company reported a basic earnings per share of -0.0012 for Q3 2020, down from -0.0022 in the same period last year[60] - The total comprehensive income for Q3 2020 was -1,294,244.21, compared to -2,314,612.81 in the same period last year[60] - The net profit for the company was -15,332,513.35 CNY, showing a significant loss compared to previous periods[66] - The basic earnings per share (EPS) was -0.0143 CNY, and the diluted EPS was also -0.0143 CNY, indicating a decline in profitability[68] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 1,272,542,553.83, an increase of 1.76% compared to the end of the previous year[18] - Total liabilities reached ¥1,219,745,420.76, compared to ¥1,206,117,580.40 previously[42] - Current liabilities totaled ¥398,418,992.72, down from ¥675,089,641.76[42] - Non-current liabilities increased to ¥821,326,428.04 from ¥531,027,938.64[42] - The total current assets as of September 30, 2020, amounted to ¥347,810,124.23, up from ¥286,749,519.46[38] - The total non-current assets were ¥760,486,827.34, slightly down from ¥760,513,545.09[47] - The company’s total current liabilities were 675,089,641.76, with short-term borrowings at 134,000,000.00 and accounts payable at 124,620,972.59[79] - Total current assets amounted to RMB 45,761,465.48, with cash and cash equivalents at RMB 8,686,569.89[83] - Total non-current liabilities stood at RMB 508,583,952.07, including long-term payables of RMB 489,194,780.00[88] - Total liabilities amounted to RMB 788,349,393.09, reflecting the company's financial obligations[88] Shareholder Information - Net assets attributable to shareholders of the listed company increased by 18.98% to CNY 52,797,133.07 compared to the end of the previous year[18] - The total number of shareholders at the end of the reporting period was 62,446[25] - The largest shareholder, Cinda Securities - Industrial Bank - Cinda Xirong No. 4 Collective Asset Management Plan, held 260,000,000 shares, accounting for 24.27% of the total shares[25] - The total equity attributable to shareholders was ¥52,797,133.07, an increase from ¥44,376,346.48[42] - Shareholders' equity totaled RMB 17,925,617.48, with paid-in capital at RMB 1,071,274,605.00[88] Cash Flow - The net cash flow from operating activities for the period was CNY -17,449,841.64, indicating a decrease of 66.75% compared to the previous year[18] - Cash flow from operating activities resulted in a net outflow of -17,449,841.64 CNY, reflecting challenges in cash generation[70] - Total cash inflow from financing activities was 550,588,530.49 CNY, primarily from loans and other financing sources[71] - The company incurred cash outflows of 279,584,502.74 CNY in investing activities, indicating ongoing investments in assets[71] - The cash and cash equivalents at the end of the period were 57,376,406.26 CNY, down from 61,480,782.87 CNY at the beginning of the period[71] - The company received 685,728,045.11 CNY in cash from sales of goods and services, showing revenue generation despite losses[70] - The company paid 33,337,627.90 CNY in taxes, reflecting its tax obligations during the period[70] - The company reported a significant increase in cash outflows for employee payments, totaling 56,937,471.11 CNY[70] Operational Insights - The company will continue to monitor the asset disposal progress of Shengyun Investment and ensure compliance with commitments to protect the interests of the company and minority shareholders[33] - The company is focusing on expanding its market presence and developing new products, although specific figures were not disclosed in the call[84] - Future outlook includes strategic initiatives aimed at enhancing operational efficiency and exploring potential mergers and acquisitions[84]